Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer
Gerald Schmid‐Bindert(Heidelberg University), Vittorio Gebbia(University of Palermo), Frank Mayer(Universitätsklinikum Tübingen), Edurne Arriola(Hospital Del Mar), Diego Márquez-Medina(Hospital Universitari Arnau de Vilanova), Kostas Syrigos, Bonne Biesma(Jeroen Bosch Ziekenhuis), Monika I. Leschinger(Eli Lilly (Germany)), Bente Frimodt‐Moller, Veronique Ripoche(Eli Lilly (United States)), Scott P. Myrand(Eli Lilly (United States)), Tuan S. Nguyen(Eli Lilly (United States)), Rebecca R. Hozak(Eli Lilly (United States)), Annamaria H. Zimmermann(Eli Lilly (United States)), Carla Visseren‐Grul(Eli Lilly (Netherlands)), Wolfgang Schuette(Krankenhaus Mara)
Cited by 11
Abstract
Related Papers
No related papers found
Powered by citation graph analysis